More Cancer Cases Tied To Breast Implants, FDA Says
Executive Summary
The US agency announced this week that it’s reviewing multiple reports of a form of carcinoma that arises in the scar tissue around a breast implant.
You may also be interested in...
New Cancer Risks Linked To Breast Implants, FDA Warns
The US FDA has learned of new cancer risks associated with breast implants that differ from cancers the agency has warned about in the past.
Worldwide Recall On Allergan Textured Breast Implants
Allergan PLC announced that it would take its Biocell textured breast implants and tissue expanders off the market worldwide shortly after the US FDA released additional information linking the use of the implants to a rare cancer.
Cases Of Rare Lymphoma Linked To Breast Implants Increase
US FDA is now aware of 414 cases of breast implant-associated anaplastic large cell lymphoma. The agency says that updated medical literature estimates of the lifetime risk of textured breast implanted patients developing BIA-ALCL range between 1 in 3,817 to 1 in 30,000.